Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: patient validity

All Smiles at the Press Conference: Plazo+Levo Delivers

Posted on February 9, 2017 by Harald — 5 Comments ↓

This December, Achaogen released much data on 2 plazomicin trials[1]: the pivotal EPIC study comparing plazomicin / levofloxacin with meropenem / levofloxacin in cUTI is the one we want to look at today because it is interpretable, while the other trial called CARE is not. CARE is one of those observational Continue reading All Smiles at the Press Conference: Plazo+Levo Delivers→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in QIDP Antibiotics, The News, The Viewpoint | Tagged Achaogen, Allphase Pharma Consulting, antibiotic blog, ASPECT-cUTI, carbavance, cefiderocol, ceftolozane/tazobactam, complicated UTI, CORE trial, cUTI, EPIC trial, eravacycline, FDA cUTI Guidance, Harald Reinhart, IGNITE2, imipenem, Levaquin, levofloxacin, meropenem, Merrem, mMITT, patient validity, plazofloxacin, plazomicin, Primaxin, S-649266, Shionogi, TANGO-1, TDM, Tetraphase, The Medicines Company, therapeutic drug monitoring, Zerbaxa | 5 Replies

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d